Royce & Associates LP reduced its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 18.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,456 shares of the financial services provider's stock after selling 27,226 shares during the period. Royce & Associates LP owned 0.18% of Houlihan Lokey worth $19,350,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of HLI. Vanguard Group Inc. boosted its holdings in shares of Houlihan Lokey by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 5,104,143 shares of the financial services provider's stock worth $654,300,000 after buying an additional 29,843 shares during the period. Earnest Partners LLC lifted its position in Houlihan Lokey by 1.9% during the 2nd quarter. Earnest Partners LLC now owns 3,273,818 shares of the financial services provider's stock worth $441,507,000 after acquiring an additional 62,314 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in Houlihan Lokey by 1.3% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,087,898 shares of the financial services provider's stock valued at $416,434,000 after acquiring an additional 38,155 shares during the period. Sei Investments Co. grew its position in shares of Houlihan Lokey by 6.2% in the second quarter. Sei Investments Co. now owns 776,335 shares of the financial services provider's stock valued at $104,697,000 after purchasing an additional 45,205 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Houlihan Lokey by 1.2% in the second quarter. Bank of New York Mellon Corp now owns 517,952 shares of the financial services provider's stock worth $69,851,000 after purchasing an additional 6,291 shares during the period. 78.07% of the stock is currently owned by institutional investors.
Houlihan Lokey Stock Performance
Shares of HLI stock traded up $0.04 during mid-day trading on Friday, reaching $184.12. The company's stock had a trading volume of 249,970 shares, compared to its average volume of 321,968. The firm's 50-day moving average is $166.88 and its two-hundred day moving average is $149.50. The company has a market cap of $12.80 billion, a P/E ratio of 37.64 and a beta of 0.65. Houlihan Lokey, Inc. has a 1-year low of $102.29 and a 1-year high of $190.66.
Houlihan Lokey (NYSE:HLI - Get Free Report) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.15. The business had revenue of $574.96 million for the quarter, compared to analysts' expectations of $537.93 million. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The firm's revenue for the quarter was up 23.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.11 earnings per share. Sell-side analysts anticipate that Houlihan Lokey, Inc. will post 5.79 EPS for the current year.
Houlihan Lokey Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Sunday, December 15th. Investors of record on Monday, December 2nd will be given a dividend of $0.57 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.28 annualized dividend and a dividend yield of 1.24%. Houlihan Lokey's dividend payout ratio (DPR) is presently 46.63%.
Wall Street Analyst Weigh In
A number of analysts have issued reports on HLI shares. Wells Fargo & Company started coverage on Houlihan Lokey in a report on Thursday, September 12th. They issued an "underweight" rating and a $149.00 target price on the stock. StockNews.com upgraded shares of Houlihan Lokey from a "hold" rating to a "buy" rating in a research note on Tuesday. UBS Group upped their target price on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a "buy" rating in a research note on Tuesday, October 8th. Morgan Stanley increased their price target on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an "equal weight" rating in a report on Monday, September 23rd. Finally, Keefe, Bruyette & Woods restated a "market perform" rating and set a $154.00 price objective (up previously from $139.00) on shares of Houlihan Lokey in a report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $157.00.
View Our Latest Report on Houlihan Lokey
Insider Buying and Selling at Houlihan Lokey
In other news, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $152.28, for a total value of $30,456.00. Following the completion of the transaction, the director now owns 6,801 shares in the company, valued at approximately $1,035,656.28. The trade was a 2.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Christopher M. Crain sold 1,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total value of $155,290.00. The disclosure for this sale can be found here. Insiders have sold 1,600 shares of company stock worth $249,860 over the last three months. Company insiders own 23.68% of the company's stock.
Houlihan Lokey Profile
(
Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Recommended Stories
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.